JBI SUMARI
sumari.jbi.global
- Free trial
- Web
What JBI SUMARI is
JBI SUMARI is a web application for managing systematic literature reviews from protocol planning through reporting. Its workflow covers team management, study selection, critical appraisal, data extraction, synthesis, and report writing. The application supports ten review types, including effectiveness, qualitative, economic evaluation, prevalence or incidence, mixed methods, umbrella or overview, diagnostic accuracy, and scoping reviews. Built-in JBI qualitative synthesis and critical appraisal tools support the stated methodology. Researchers can import multiple citation files, review import history, undo or remove uploads, and identify exact or potential duplicates. Screening decisions can produce an exportable PRISMA 2020 flow diagram. SUMARI connects with JBI evidence-based resources, while data is saved and backed up on secure JBI SUMARI servers. It targets researchers and practitioners in health, social sciences, and humanities. Access requires a free MYJBI account. Individual subscriptions cost $130 a year and include a 14-day free trial.
Who it suits
It is intended for researchers and practitioners in health, social sciences, and humanities conducting structured literature reviews. Teams needing screening, appraisal, extraction, synthesis, and reporting tools may find its workflow suitable.
Good to know, and what to watch
- Supports ten systematic review types
- Includes team management and collaboration workflow
- Automatic duplicate checking and PRISMA export
- Built-in JBI appraisal and qualitative synthesis tools
- 14-day trial for individual subscriptions
- No free plan
- Individual subscription costs $130 a year
- Not validated as a clinical screening or diagnostic tool
- Organization subscription pricing requires contact
Plans
Every plan and priceOrganization subscription
Individual subscription
14-day trial
The verdict
JBI SUMARI brings major systematic-review stages into one web workflow with JBI-specific tools and reporting support. Its paid model and clinical-use restriction are important considerations before adoption.
What the maker publishes
- Account access
- Users must create a MYJBI account to access JBI SUMARI, and creating that account is free. source
- Clinical use limit
- The terms state that SUMARI is not a screening or diagnostic tool and has not been validated for clinical use. source
- Data storage
- The home page says data is saved and backed up to secure JBI SUMARI servers. source
- Deduplication and reporting
- New records are automatically checked for exact duplicates, potential duplicates can be flagged, and screening decisions generate an exportable PRISMA 2020 flow diagram. source
- Founded
- 1996 source
- Headquarters
- North Adelaide, South Australia, Australia source
- Integrations
- The support page describes integration with JBI evidence-based resources for methodological consistency. source
- Methodology
- JBI SUMARI includes built-in functionality for JBI qualitative synthesis and embedded JBI critical appraisal tools. source
- Publisher and owner
- JBI, a business unit of Adelaide University, owns the product and operates its website. source
- Purpose
- JBI SUMARI is a web application for conducting systematic reviews of literature, from protocol development through reporting. source
- Record import
- Users can import multiple citation files at once, track import history, and undo or remove uploaded files. source
- Research fields
- The software is designed for researchers and practitioners in health, social sciences, and humanities. source
- Review types
- It supports ten review types, including effectiveness, qualitative, economic evaluation, prevalence or incidence, mixed methods, umbrella or overview, diagnostic accuracy, and scoping reviews. source
- Review workflow
- Its workflow covers team management, study selection, critical appraisal, data extraction, data synthesis, and review report writing. source
- Support
- Users can access a SUMARI knowledge base and contact the JBI support desk; organizational subscribers are directed to their appropriate support contact. source
- Trial
- The pricing page offers a 14-day free trial for individual subscriptions. source
Checked against the maker's pages on 8 Oct 2026.